Related Experiment Video
Updated: Jan 22, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
Veit Phillip1, Aldis Pukitis2, Alexey Epstein3
1Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar, Technische Universität München, München, Germany.
Pancreatic stenting effectively prevents post-ERCP pancreatitis (PEP) in patients with inadvertent pancreatic duct cannulation during first-time ERCP. This safe procedure significantly reduces PEP risk in an unselected population.
Area of Science:
- Gastroenterology
- Interventional Endoscopy
Background:
- Acute pancreatitis (AP) is a common cause of hospitalization.
- Post-ERCP pancreatitis (PEP) is a frequent complication of ERCP.
- Pancreatic stenting is a potential prophylactic measure against PEP.
Purpose of the Study:
- To investigate the risk of PEP following inadvertent pancreatic duct cannulation during first-time ERCP.
- To evaluate the efficacy of prophylactic pancreatic stenting in reducing PEP.
- To determine if pancreatic stenting benefits an unselected patient population.
Main Methods:
- A multicenter, prospective, randomized controlled trial involving 167 patients undergoing first-time ERCP.
- Patients with inadvertent pancreatic duct cannulation were randomized to receive either a pancreatic stent or no routine intervention.
- Data were analyzed to compare PEP rates between the two groups.
Main Results:
- Prophylactic pancreatic stent insertion significantly reduced the rate of PEP (OR 0.43; P=0.04).
- The number needed to treat to prevent one case of PEP was 8.1.
- Pancreatic stenting was found to be a safe and feasible intervention.
Conclusions:
- Inadvertent pancreatic duct cannulation during first-time ERCP poses a significant risk of PEP.
- Prophylactic pancreatic stenting is an effective strategy to mitigate this risk.
- Pancreatic stenting is a safe and feasible prophylactic measure for patients undergoing ERCP.
Related Concept Videos
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Endoscopic Procedures V: ERCP
Patient...

